Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-58
Closed -$3K 7429
2020
Q3
$3K Hold
58
﹤0.01% 7205
2020
Q2
$3K Buy
+58
New +$2.56K ﹤0.01% 7350
2019
Q3
Sell
-581
Closed -$28K 7713
2019
Q2
$28K Buy
+581
New +$28K ﹤0.01% 6906

Other funds holding ENOV

Citigroup's ENOV Position: Q2 2026 in Review

Citigroup increased its Enovis (ENOV) stake by 3,865% in Q2 2026, buying an estimated $8.85M and bringing the position to 385,220 shares worth $7.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Citigroup first reported a position in ENOV in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.5M in Q1 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Citigroup held 385,220 shares of Enovis worth $7.97M as of Q2 2026.
  • Citigroup bought 375,505 Enovis shares in Q2 2026, an estimated $8.85M.
  • Enovis made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1774 holding.
  • Citigroup first reported a position in Enovis in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Enovis position peaked at $12.5M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.